Posted by Two Blokes
Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, h
Source: Two Blokes Trading
Posted by Two Blokes
Higher dose of Wegovy \u00ae provided average weight loss of 21% in people with obesity – with a third achievi
Source: Two Blokes Trading
Posted by Two Blokes
Onto Innovation (ONTO) closed the most recent trading day at $95.82, moving 1.19% from the previous trading se
Source: Two Blokes Trading
Posted by Two Blokes
In the most recent trading session, M-tron Industries, Inc. (MPTI) closed at $39.56, indicating a -1.3% shift
Source: Two Blokes Trading
Posted by Two Blokes
In the closing of the recent trading day, MakeMyTrip (MMYT) stood at $91.65, denoting a -2.94% move from the p
Source: Two Blokes Trading
Posted by Two Blokes
Lightspeed Commerce Inc. (LSPD) concluded the recent trading session at $10.89, signifying a -2.77% move from
Source: Two Blokes Trading
Posted by Two Blokes
In the closing of the recent trading day, Crocs (CROX) stood at $98.52, denoting a -1.61% move from the preced
Source: Two Blokes Trading
Posted by Two Blokes
Randomized, controlled clinical trial presented as a late-breaking poster at ADA's Scientific Sessions shows p
Source: Two Blokes Trading
Posted by Two Blokes
SAN FRANCISCO, June 20, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage
Source: Two Blokes Trading
Posted by Two Blokes
Tariff volatility rocked markets for much of the second quarter, creating pressure on U.S. bonds and equities.
Source: Two Blokes Trading
Posted by Two Blokes
Bagsværd, Denmark, 20 June 2025 – Novo Nordisk announces subcutaneous amycretin data being presented at the Am
Source: Two Blokes Trading
Posted by Two Blokes
Higher dose of Wegovy \u00ae provided average weight loss of 21% in people with obesity – with a third achievi
Source: Two Blokes Trading